Mucosamin is clinically proven to prevent and treat oral mucositis and related oral problems. The patented combination of sodium hyaluronate and synthetic amino acids helps to hydrate and protect the oral mucosa.3,4,5
for Oral Mucositis and Dry Mouth Conditions
Prevent - Soothe - Heal
Indicated for the treatment of oral mucositis due to radiotherapy or chemotherapy and other dry mouth conditions.2
When used before the start of chemotherapy or radiotherapy, helps to reduce the incidence of mucositis.1
Helps reduce pain and burning sensations. Provides short and long-term pain relief.3 Well tolerated across all age groups. No reported adverse events or drug interactions.4
Forms a protective layer that covers ulcerated mucosa and helps promote the wound healing process.3
Progressively improves ability to swallow foods and liquids. May help reduce treatment interruptions.4
Mucosamin products are available on prescription through the NHS Drug Tariff.
Patented Formula for Mucosal Protection and Healing
Patented Combination:
Glycine, L-Proline, L-Leucine, L-Lysine HCl
Quick reference guide. For complete instructions, please refer to each product's Instructions For Use (IFU)
250ml
30ml
Evidence-Based Treatment
Mucosamin is used for the prevention and treatment of oral mucositis in patients undergoing radiotherapy and/or chemotherapy. Mucositis is a common side effect of cancer treatment that causes the lining of the mouth to become sore and inflamed.
Mucosamin Mouthwash is indicated for:
Mucosamin Spray is indicated for:
Both products hydrate the oral mucosa and have a protective action on it. The full indications are in each product's Instructions for Use.
Mucosamin can be used by patients experiencing mucositis from cancer treatment, those with dry mouth conditions and burning mouth syndrome.
Yes, for the mouth symptoms covered by its Instructions for Use. Mucosamin Mouthwash is indicated for burning mouth syndrome, including burning mouth syndrome secondary to Sjögren's syndrome (also called Sjögren's disease). It is a topical oral solution that hydrates the oral mucosa and has a protective action on it: it forms a film that covers and protects the mucosa, which helps to reduce pain and burning sensations, while its hyaluronic acid and amino acids help the repair of the mucosa.
Use 5-10 ml three or four times a day, keep it in the mouth for at least one minute and do not rinse afterwards.
If you have Sjögren's, your rheumatologist, dentist or GP can advise whether it is suitable for you. It is available on NHS prescription (Drug Tariff Part IXA) and to buy online.
Yes. A randomised clinical study followed 60 adults with burning mouth syndrome secondary to local causes for one month. Half used the Mucosamin formulation, applied as Mucosamin Spray three times a day, and half used sodium bicarbonate rinses. After 30 days the oral mucosa had improved by at least one grade in 79% of the Mucosamin group compared with 57% of the bicarbonate group; pain fell in both groups, and patient satisfaction was significantly higher with Mucosamin.6
Mucosamin Mouthwash is indicated for burning mouth syndrome, including burning mouth syndrome secondary to Sjögren's syndrome.
Mucosamin contains a patented formulation of sodium hyaluronate and four synthetic amino acids: glycine, L-proline, L-leucine, and L-lysine HCl. These amino acids assist in wound repair protecting healthy tissue (mucosa) from damage whilst supporting wound healing.
Use three or four times (or more) a day according to the severity of the symptoms.
Important: Both Mouthwash and Spray can be used during treatment. Combine with a diet free of spicy or acidic foods.
Mucosamin can be used throughout your treatment journey. It may be used pre-treatment to help protect the oral mucosa, during treatment for pain relief and symptom management, and post-treatment for healing and recovery.
For optimal prevention, treatment should ideally commence before the start of radiotherapy or chemotherapy.
For dry mouth conditions, Mucosamin can be used when symptoms are present to provide relief and maintain oral comfort.
Safety Profile: Mucosamin has been evaluated across nine clinical studies involving 679 patients with no adverse events reported.
The only contraindication is known hypersensitivity to any of the ingredients. There are no reports of interactions with drugs or medicinal substances. There are no known secondary effects during pregnancy and breastfeeding, however use should be at healthcare professional's discretion.
Mucosamin should be stored between 8°C and 30°C in a cool, dry place away from moisture and heat sources. Do not store in the refrigerator. Do not use if packaging has been opened or damaged, or after the expiry date. Keep out of reach of children.
Prescription: Mucosamin Mouthwash and Mucosamin Spray may be prescribed by your GP or hospital consultant.
NHS Drug Tariff: Both products are listed in the NHS Drug Tariff Part IXA.
Purchase Online: Available for purchase through our online Shopify store at Shopify or Amazon UK or through specialist healthcare suppliers.
250ml
PIP Code: 408-8464
30ml
PIP Code: 408-8480
Mucosamin is supported by nine comprehensive clinical studies involving 679 patients. This represents one of the most extensive clinical databases for oral mucositis management.
Real Experiences from Mucosamin Users
For Medical Information and Enquiries